These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 985884)
1. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones. Walter R; Smith CW; Roy J; Formento A J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884 [TBL] [Abstract][Full Text] [Related]
2. Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins. Stahl GL; Walter R J Med Chem; 1977 Apr; 20(4):492-5. PubMed ID: 850233 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with L-3,4-dehydroproline in position 7. Moore S; Felix AM; Meienhofer J; Smith CW; Walter R J Med Chem; 1977 Apr; 20(4):495-500. PubMed ID: 850234 [TBL] [Abstract][Full Text] [Related]
4. Synthetic metabolites of neurohypophyseal hormones. (Des-9-glycinamide)oxytocin and (des-9-glycinamide, des-8-leucine)oxytocin. Walter R; Havran RT; Schwartz IL J Med Chem; 1976 Feb; 19(2):328-30. PubMed ID: 1249815 [TBL] [Abstract][Full Text] [Related]
5. Oxytocin and lysine-vasopressin with N5,N5-dialkylglutamine in the 4 position: effect of introducing sterically hindered groups into the hydrophilic cluster of neurohypophyseal hormones. Stahl GL; Smith CW; Walter R; Tsegenidis T; Stavropoulos G; Cordopatis P; Theodoropoulos D J Med Chem; 1980 Feb; 23(2):213-7. PubMed ID: 7359537 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and some pharmacological properties (4-beta-(2-thienyl)-L-alanine)oxytocin. Smith CW; Skala G; Walter R J Med Chem; 1978 Jan; 21(1):115-7. PubMed ID: 619140 [TBL] [Abstract][Full Text] [Related]
7. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin. Roy J; Roy U; Gazis DC; Schwartz IL Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004 [TBL] [Abstract][Full Text] [Related]
8. Conformation-activity studies of oxytocin. Effects of structural modifications at corner positions of the beta-turns on the uterotonic activity. Smith CW; Botos CR; Skala G; Walter R J Med Chem; 1977 Nov; 20(11):1457-60. PubMed ID: 915905 [TBL] [Abstract][Full Text] [Related]
9. Hydroxy analogues of oxytocin and of lysine-vasopressin. Bisset GW; Chowdrey HS; Hope DB; Nilwises N; Wälti M Br J Pharmacol; 1979 Dec; 67(4):575-85. PubMed ID: 519108 [TBL] [Abstract][Full Text] [Related]
10. Active-site studies of neurohypophyseal hormones: synthesis and pharmacological properties of [5-(N4,N4-dimethylasparagine)]oxytocin. Walter R; Stahl GL; Caplaneris T; Cordopatis P; Theodoropoulos D J Med Chem; 1979 Jul; 22(7):890-3. PubMed ID: 448689 [TBL] [Abstract][Full Text] [Related]
11. Replacement of the disulfide bond in oxytocin by an amide group. Synthesis and some biological properties of (cyclo-(1-L-aspartic acid,6-L-alpha,beta-diaminopropionic acid))oxytocin. Smith CW; Walter R; Moore S; Makofske RC; Meienhofer J J Med Chem; 1978 Jan; 21(1):117-20. PubMed ID: 619141 [TBL] [Abstract][Full Text] [Related]
12. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1. Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin. Grzonka Z; Lammek B; Gazis D; Schwartz IL J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771 [TBL] [Abstract][Full Text] [Related]
14. Some pharmacological actions of four synthetic analogues of oxytocin. BERDE B; DOEPFNER W; KONZETT H Br J Pharmacol Chemother; 1957 Jun; 12(2):209-14. PubMed ID: 13446374 [TBL] [Abstract][Full Text] [Related]
15. Oxytocin analogs with oxygen-containing side chains in position 3. Gazis D; Schwartz IL; Cordopatis P; Theodoropoulos D Int J Pept Protein Res; 1986 Jun; 27(6):679-84. PubMed ID: 3759339 [TBL] [Abstract][Full Text] [Related]
16. Biofunctional evaluation of two hydrogen bonds stabilizing the beta-turn in the acyclic component of oxytocin. Roy U; Gazis D; Schwartz IL; Roy J Int J Pept Protein Res; 1983 Oct; 22(4):398-403. PubMed ID: 6654586 [TBL] [Abstract][Full Text] [Related]
17. Biofunctional evaluation of a hydrogen bond stabilizing the beta-turn in the acyclic part of oxytocin. Roy J; Johnson M; Gazis D; Schwartz IL Int J Pept Protein Res; 1980 Jul; 16(1):55-60. PubMed ID: 7192272 [TBL] [Abstract][Full Text] [Related]
18. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8. Flouret G; Chaloin O; Slaninová J J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485 [TBL] [Abstract][Full Text] [Related]
19. Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule. Kowalczyk W; Prahl A; Derdowska I; Sobolewski D; Olejnik J; Zabrocki J; Borovicková L; Slaninová J; Lammek B J Med Chem; 2006 Mar; 49(6):2016-21. PubMed ID: 16539389 [TBL] [Abstract][Full Text] [Related]
20. [5-(N4,N4-Dimethylasparagine),8-lysine]vasopressin: the first 5-position neurohypophyseal hormone analogue to retain to retain significant antidiuretic potency. Smith CW; Walter R; Stavropoulos G; Theodoropoulos D J Med Chem; 1980 Feb; 23(2):217-9. PubMed ID: 7359538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]